Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Ancon Medical Disease Screening Technology Adapted for Veterinary Medicine
  • USA - English


News provided by

Ancon Medical Inc

Sep 05, 2015, 09:00 ET

Share this article

Share toX

Share this article

Share toX

Ancon Medical will help detect diseases in Dogs and Cats
Ancon Medical will help detect diseases in Dogs and Cats

Bloomington, MN (PRWEB) September 05, 2015 -- Ancon Medical Inc. is adapting its innovative health screening technology for veterinary services, giving veterinarians who specialize in animal care an easy, quick, non-invasive method for finding and treating diseases in cats and dogs.

Ancon Medical’s Nanoparticle Biomarker Tagging (NBT) is a leading-edge disease screening technology that can screen and detect the presence of a range of diseases by measuring for certain molecules in the exhaled breath of a subject.

One of Ancon’s hallmark benefits is that it doesn’t require needles, putting an animal to sleep, skin grafts or other painful methods of sample collection to provide fast, accurate results

Post this

Ancon Medical’s NBT device provides a quick, efficient and simple screening diagnostic tool that answers the basic needs of both animal owners and veterinarians. Plus, NBT technology provides an ideal diagnostic solution for veterinarians who work both with cats and dogs.

NBT has already proven effective in disease screening for people, as it provides both a non-invasive and fast method to test for a wide range of diseases, including certain cancers, Lyme disease, COPD and others.

NBT works by detecting “biomarkers” in exhaled breath, using a process similar to ultrafast gas chromatography. These molecule-sized volatile organic compound metabolites are specific to certain diseases and once discovered, an NBT device can be programmed to search for these biomarkers. So far, researchers have found biomarkers for a range of diseases.

The NBT process will work the same for animals as it does for humans. First, the precise biomarkers for specific animal diseases will be discovered through clinical research working closely with specialist universities. Then, the NBT device will be programmed to detect these biomarkers in the breath of cats or dogs.

In addition to its versatility, Ancon Medical’s NBT technology provides an unobtrusive method for performing diagnostic tests on animals.

“One of NBT’s hallmark benefits is that it doesn’t require needles, putting an animal to sleep, skin grafts or other painful methods of sample collection to provide fast, accurate results,” Ancon Medical CEO Wesley Baker said. “Invasive procedures like these can make diagnostic testing for animals difficult for both owners and the veterinarian. But with NBT’s breath detection technology, animals can receive timely, comprehensive disease screening without suffering the stress it puts on them and their people.”

Veterinarians are placing a greater emphasis on animal wellness and health, with animals receiving regularly scheduled checkups and improved focus on preventative help. One of the advantages of NBT technology is that it is fast, producing results in as little as 15 minutes.

Since animal testing can take between one to 10 days to produce diagnostic results, pet owners often have to make two trips or more to the veterinarian to complete an animal test. Plus, diagnosing animals can often require several tests before producing conclusive results, which not only adds more stress for the animal, it also drives up costs.

Veterinarians play an important role in diagnosing animals, making a user-friendly diagnostic tool like an NBT device a valuable addition to the practice as it allows testing in more cases and by a wider range of support staff.

“With an NBT device, veterinary offices can run tests in many situations where they normally wouldn’t, because it is easy to use and to train staff to operate, and it’s a more pleasant experience for both animal and owner,” Baker said.

The NBT is also a valuable device for the agricultural industry, as there is a growing need for more diagnostic devices on farms to directly monitor livestock health. Having the power to identify, treat and possibly isolate diseased livestock will help boost the industry’s productivity.

With a proposed price of around $30,000 and attractive leasing options, Ancon Medical’s NBT device can be an affordable addition to any veterinary office, while its small size makes it comfortable and easy to use.

Ancon Medical is an active member of LifeScience Alley, a biomedical trade association based in Minnesota.

# # # #

Wesley Baker, Ancon Medical Inc, http://www.anconmedical.com, +1 (612) 284-5354, [email protected]

Modal title

Ancon Medical will help detect diseases in Dogs and Cats
Ancon Medical will help detect diseases in Dogs and Cats
PDF Ancon Medical Veterinary Release
View PDF
PDF Ancon Medical Veterinary Release
Ancon Medical NBT V005
Ancon Medical NBT V005
Ancon Medical Logo
Ancon Medical Logo
Ancon Medical will help detect diseases in Dogs and Cats PDF Ancon Medical Veterinary Release Ancon Medical NBT V005 Ancon Medical Logo

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.